During the past decade, Centre d'Oncologie et de Radiothérapie du Pays-Basque conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "UNICANCER" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" are "Breast Cancer" (3 trials), "Lymphoma" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma of Lung Metastatic to Brain" (1 trials) and "Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II)" (1 trials). Many other conditions were trialed in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" in a lesser frequency.

Most popular intervention types in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" are "Drug" (12 trials), "Other" (5 trials), "Radiation" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "LV5FU2" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre d'Oncologie et de Radiothérapie du Pays-Basque" are 13 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre d'Oncologie et de Radiothérapie du Pays-Basque". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre d'Oncologie et de Radiothérapie du Pays-Basque, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre d'Oncologie et de Radiothérapie du Pays-Basque, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".